The technology has generated notices with errors, sent Medicaid paperwork to the wrong addresses, and been frozen for hours at a time, according to state audits, court documents, and interviews. While it can take months to fix problems, America’s poorest residents pay the price.
Health policy may not be the top issue in this year’s presidential and congressional elections, but it’s likely to play a key role. President Joe Biden and Democrats intend to hold Republicans responsible for the Supreme Court’s unpopular ruling overturning the right to abortion, and former President Donald Trump aims to take credit for government efforts to lower prescription drug prices — even in cases in which he played no role. Meanwhile, some critical health care issues, such as those involving Medicaid and the Affordable Care Act, are unlikely to get discussed much, even though the party in power after the elections would control the future of those programs. This week, in an episode taped before a live audience at the Aspen Ideas: Health festival in Aspen, Colorado, Margot Sanger-Katz of The New York Times and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these issues and more.
Gov. Gavin Newsom wants to pull funds earmarked for new investment in Medi-Cal to help plug California’s $45 billion deficit. A state budget passed June 13 by the legislature largely endorsed Newsom’s plan. Voters could settle the matter in an industry-backed initiative that has qualified for the November ballot.
Lawmakers passed a budget that rejected Gov. Gavin Newsom’s proposal to save nearly $95 million by eliminating in-home support services for qualifying older, blind, and disabled immigrants lacking legal residency. Advocates say Newsom’s plan would have cost more in the long run. Newsom has not indicated whether he’ll veto.
The Supreme Court has dismissed a challenge to the FDA’s approval of the abortion pill mifepristone, ruling unanimously that the anti-abortion doctor group that filed the suit lacked standing. But abortion opponents are expected to pursue other strategies to ban or restrict the medication. Meanwhile, the Biden administration moves to stop the inclusion of medical debt on individual credit reports, and former President Donald Trump tries to claim credit for $35 insulin. Anna Edney of Bloomberg News, Rachana Pradhan of KFF Health News, and Emmarie Huetteman of KFF Health News join KFF Health News chief Washington correspondent Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF president and CEO Drew Altman about KFF’s new “Health Policy 101” primer.
An Alameda County mother has spent 10 months seeking help for her 4-year-old son’s speech and behavior issues from his school district and her Medicaid health insurer. She still doesn’t have an answer.
In this episode of “An Arm and a Leg,” the show takes its first look at Medicaid. The program has dropped more than 22 million people since spring 2023, when covid-era protections ended.
One of Montana’s largest safety-net health centers announced it will lay off nearly 10% of its workforce because of revenue losses it attributes to vast Medicaid disenrollments. Such cuts are happening elsewhere too.
While Republican candidates in many states downplay their opposition to abortion, the most vehement wing of the movement, which helped overturn Roe v. Wade — those who advocate prosecuting patients, outlawing contraception, and banning IVF — are increasingly outspoken. Meanwhile, some state legislatures continue to advance new restrictions, like a proposal moving in Louisiana to include abortion medications mifepristone and misoprostol on the list of the most dangerous drugs. Alice Miranda Ollstein of Politico, Rachel Roubein of The Washington Post, and Joanne Kenen of the Johns Hopkins schools of public health and nursing and Politico Magazine join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Shefali Luthra of The 19th about her new book on abortion in post-Roe America, “Undue Burden.”
California’s Medicaid program is testing a novel approach for people addicted to methamphetamine, cocaine, and other stimulants. For every clean urine test, they can earn money — up to $599 a year.
